CDT Conduit Pharmaceuticals
- 0.075
- +0.009+13.87%
- 0.071
- -0.004-5.09%
Conduit Pharmaceuticals News
424B3: Prospectus
424B3: Prospectus
EFFECT: Others
424B5: Prospectus
424B3: Prospectus
EFFECT: Others
424B3: Prospectus
EFFECT: Others
424B3: Prospectus
424B3: Prospectus
EFFECT: Others
Conduit Pharmaceuticals | 424B3: Prospectus
Conduit Pharmaceuticals | EFFECT: Others
Murphy Canyon Acquisition Corp | 8-A12B: Registration of a class of securities on a national securities exchange
Murphy Canyon Acquisition Corp | 424B3: Prospectus
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Murphy Canyon Acquisition Corp | 424B3: Prospectus
No Data
